Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Daiichi Sankyo
Colorcon
Harvard Business School
Federal Trade Commission
Chubb
Cantor Fitzgerald
Mallinckrodt
Express Scripts

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 016295

« Back to Dashboard

NDA 016295 describes HYDREA, which is a drug marketed by Bristol Myers Squibb and is included in one NDA. It is available from one supplier. Additional details are available on the HYDREA profile page.

The generic ingredient in HYDREA is hydroxyurea. There are ten drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the hydroxyurea profile page.
Summary for 016295
Tradename:HYDREA
Applicant:Bristol Myers Squibb
Ingredient:hydroxyurea
Patents:0
Therapeutic Class:Antineoplastics
Formulation / Manufacturing:see details
Pharmacology for NDA: 016295
Ingredient-typeUrea
Suppliers and Packaging for NDA: 016295
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DROXIA hydroxyurea CAPSULE;ORAL 016295 NDA E.R. Squibb & Sons, L.L.C. 0003-0830 N 0003-0830-50
DROXIA hydroxyurea CAPSULE;ORAL 016295 NDA E.R. Squibb & Sons, L.L.C. 0003-6335 N 0003-6335-17

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength500MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength200MG
Approval Date:Feb 25, 1998TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength300MG
Approval Date:Feb 25, 1998TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Covington
UBS
AstraZeneca
Colorcon
Medtronic
Fuji
Dow
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.